Almonds
OtherWhole raw almonds provided as a mid-morning snack - 0.9g\\kg
NCT Number: NCT02480582
The current study will examine the effect of almond consumption (0.9g/kg dose) compared to an energy and weight matched comparator food or no food on measures of appetite control including appetite sensations, energy intake and food hedonics.
Looking for future studies?
Notify Me18 year–55 year
Female
Interventional
Not applicable
Some individuals exhibit a weak satiety response to food and may be susceptible to overconsumption. Snack foods can be substantial contributors to daily energy intake, with different types of snacks exerting potentially different effects on satiety per calorie consumed. The current study will compare the effect of consuming different snack foods on measures of appetite control including appetite sensations, energy intake and food hedonics in women with a weak satiety response.
In a crossover design, female participants will consume three different mid-morning snacks: raw almonds, savoury crackers or water. Appetite sensations, energy intake, food reward and craving will be assessed under controlled laboratory conditions. Satiety responsiveness will be determined using the satiety quotient (SQ).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Whole raw almonds provided as a mid-morning snack - 0.9g\\kg
Cheese savoury crackers provided as a mid-morning snack - 0.9g/kg
Time frame: 3 Weeks
Measured reductions in ad-libitum energy intake following consumption of almonds as a mid-morning snack compared to control and comparator. Food will be weighed pre- and post-consumption to the nearest 0.1g to determine energy intake. Test meal energy intake will be measured on three occasions, on average a week apart.
Time frame: 3 Weeks
Measured changes in wanting for high fat food food following consumption of almonds as a mid-morning snack compared to control and comparator.
Food preference will be measured once during each intervention condition using the Leeds Food Preference Questionnaire (LFPQ: Finlayson, King & Blundell, 2008).
8 high fat foods and 8 low fat foods are presented on a computer and participants rate the extent to which they want each food (How much do you want this food now?). The food images are presented individually, in a randomised order and participants make their ratings using a 100-mm VAS. Low fat scores are subtracted from high fat scores to provide a relative preference score.
Scale range: -100 to 100. Higher scores indicate greater wanting for high fat foods which is interpreted as a worse outcome.
Time frame: 3 Weeks
Measured differences in hunger following consumption of almonds as a mid-morning snack compared to control and comparator.
Appetite sensations will be measured during the three intervention conditions at regular time intervals from the morning to the evening (21 in total) using 100-mm visual analogue scale (VAS).
Scale range = 0-100 mm, with higher values indicating greater hunger. Total Area Under the Curve will be calculated from the VAS profiles using the trapeziodal method.
Time points at which data were collected to calculate AUC - -5, 15, 30, 60, 90, 120, 135, 180, 230, 240, 270, 280, 300, 360, 420, 480, 510, 540, 600; -5 to 8 hours post intervention.
Higher AUC scores on hunger are interpreted as a worse outcome.
Time frame: 3 Weeks
Measured reductions in total within-day energy intake following consumption of almonds as a mid-morning snack compared to control and comparator. Food will be weighed pre- and post-consumption to the nearest 0.1g, at every test meal, to determine energy intake. Total energy intake will then be calculated. 24 hour energy intake will be measured on three occasions, on average a week apart.
University of Leeds
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02122224
Body Weight, Dietary Modification
Lafayette, Indiana, United States
View Trial DetailsNCT01587911
Appetite Disorders, Excess Intake of Macronutrients
Davis, California, United States
View Trial DetailsNCT02471092
Glucose Metabolism Disorders, Hyperglycemia
Guelph, Ontario, Canada
View Trial DetailsNCT02897570
Attention Deficit and Disruptive Behavior Disorders, Behavior
San Donato Milanese, MI, Italy
View Trial Details